Substance Abuse Treatment Market to Reach $38.86 Billion by 2035

Substance abuse treatment market was valued at $16.03 billion in 2025 and is projected to reach $38.86 billion by 2035, growing at a CAGR of 9.2% during the forecast period (2026–2035). The rising global burden of substance use disorders, combined with increasing government intervention and expanding access to treatment services, is significantly driving market growth. Governments across major economies are strengthening public health frameworks to address opioid, alcohol, and nicotine dependence through structured treatment programs, reimbursement expansion, and awareness campaigns. Treatment approaches such as medication-assisted treatment (MAT), behavioral therapy, and counseling programs are gaining strong traction due to their effectiveness in improving recovery outcomes and reducing relapse rates.

Browse the full report description of “Substance Abuse Treatment Market Size, Share & Trends Analysis Report, By Treatment Type (Detoxification (Detox), Behavioral Therapy, Medication-Assisted Treatment (MAT), Counselling & Support Programs), By Drug Class (Opioid Antagonists, Partial Opioid Agonists, Full Agonists, Alcohol Dependence Medications, Smoking Cessation Products, Others), By Substance Type (Alcohol Dependence, Opioid Addiction, Tobacco/Nicotine Addiction, Cannabis Use Disorder, Stimulant Addiction, Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/substance-abuse-treatment-market

According to the Centers for Disease Control and Prevention (CDC), over 107,000 drug overdose deaths were recorded in the United States in 2023, reflecting a continued public health crisis. Similarly, the World Health Organization (WHO) estimates that harmful alcohol use contributes to approximately 3 million deaths globally each year, representing 5.3% of all deaths. These statistics underscore the urgent need for comprehensive treatment solutions, directly supporting demand growth in the substance abuse treatment market. Increasing healthcare expenditure and policy-driven initiatives are further enhancing accessibility to structured treatment programs across developed and emerging economies.

US Policy Expansion and Opioid Crisis Response Driving Treatment Adoption

In the United States, government-led initiatives to combat the opioid epidemic are significantly accelerating the adoption of substance abuse treatment solutions. In 2024, the U.S. Department of Health and Human Services (HHS) expanded funding under the State Opioid Response (SOR) grants program, allocating over $1.5 billion to support prevention, treatment, and recovery services. Additionally, regulatory changes have eased restrictions on prescribing medications such as buprenorphine, improving patient access to medication-assisted treatment (MAT).

These developments are strengthening treatment infrastructure and encouraging healthcare providers to adopt integrated care models combining pharmacological and behavioral therapies. The increasing availability of opioid antagonists and partial agonists is enhancing treatment effectiveness while reducing overdose risks. As a result, the opioid addiction segment remains a dominant contributor to market growth, supported by sustained policy backing and rising patient enrollment in treatment programs.

Innovation and Strategic Expansion: Transforming the Substance Abuse Treatment Market

The key players in the substance abuse treatment market include Johnson & Johnson (Kenvue/Nicorette), Indivior PLC, Haleon plc (Nicotinell/Nicorette), Alkermes plc, and Emergent BioSolutions Inc., among others. These companies are actively investing in product innovation, expanding treatment portfolios, and strengthening distribution networks to address the growing demand for addiction treatment solutions.

• In January 2026, Emergent BioSolutions strengthened its position in the substance abuse treatment market through U.S. FDA approval of an updated over-the-counter NARCAN Nasal Spray featuring a new portable carrying case. This innovation enhances accessibility, discretion, and everyday usability, addressing low public adoption of naloxone despite rising opioid risks. The development reflects a strategic focus on improving emergency preparedness and expanding real-world usage of overdose-reversal treatments.
• In March 2023, Indivior PLC acquired Opiant Pharmaceuticals, expanding its addiction treatment pipeline. The acquisition adds late-stage asset OPNT003, a novel intranasal opioid overdose treatment targeting synthetic opioids like fentanyl. This move enhances Indivior’s scientific capabilities and broadens its portfolio across opioid, alcohol, and cannabinoid use disorders.

Market Coverage

• The market number available for – 2025–2035
• Base year – 2025
• Forecast period – 2026–2035
• Segment Covered –
• By Treatment Type
• By Drug Class
• By Substance Type
• Competitive Landscape – Johnson & Johnson (Kenvue/Nicorette), Indivior PLC, Haleon plc (Nicotinell/Nicorette), Alkermes plc, and Emergent BioSolutions Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Substance Abuse Treatment Market Segment

By Treatment Type

• Detoxification (Detox)
• Behavioral Therapy
• Medication-Assisted Treatment (MAT)
• Counseling & Support Programs

By Drug Class

• Opioid Antagonists
• Partial Opioid Agonists
• Full Agonists
• Alcohol Dependence Medications
• Smoking Cessation Products
• Others

By Substance Type

• Alcohol Dependence
• Opioid Addiction
• Tobacco/Nicotine Addiction
• Cannabis Use Disorder
• Stimulant Addiction
• Others

Global Substance Abuse Treatment Market Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/substance-abuse-treatment-market